Skip to main content

Name
Jummy Oladipo

Wed, 11/11/2020 - 16:09

Thank you, Melinda for a comprehensive summary of the talk. Additionally, thank you Dr. Guillaume Richard-Carpentier for taking the time to speak with us. It was very inspiring to hear from a new faculty member here at Queen's. One thing that interested me during our discussion was the cost of these newly developed drugs that are showing great efficacy against AML. Dr. Richard-Carpentier elaborated on the challenges of having patients who are well-informed on the potential therapeutics available for treating their cancer, yet they may not be covered under their insurance. This dampens the translatability of these drugs into patient care by posing a large financial barrier. It was also interesting to hear the role that physicians play in advocating on the behalf of patients for the reduced pricing of drugs. While physicians may not have a direct influence through discussing with pharmaceutical companies, the successful outcomes of using these drugs in clinical settings may influence these companies to offset some of the costs. Thank you Dr. Guillaume Richard-Carpentier for your insight.

Name
Jummy Oladipo

Plain text

  • No HTML tags allowed.
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.